Cheung Sing Wan, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 121 South 7th Ave, Suite B, Barstow, CA 92311 Phone: 760-256-8791 Fax: 760-256-8710 |
News Archive
A newly designed three-part molecule could be the one answer patients with a certain form of breast cancer are looking for, scientists report.
Results from a five-year study of treatment-naïve patients with relapsing-remitting multiple sclerosis (RRMS) demonstrated that patients treated with COPAXONE (glatiramer acetate injection) showed significant reduced loss of brain volume compared to patients treated with other disease modifying therapies.
Philips Healthcare, a global leader in the health technology market, has signed a non-exclusive patent license agreement with the U.S. Air Force Research Laboratory for a mobile software application that provides integrated, real-time patient monitoring.
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that it has entered into a Memorandum of Understanding (MoU) with FusionVax, Inc. ("FusionVax") setting forth the main terms under which Advaxis will, subject to the entry of a definitive agreement, exclusively license its lead clinical stage product candidate, ADXS-HPV, to FusionVax for Asia.
› Verified 3 days ago